Interestingly, LCN2 levels in serum and cerebrospinal fluid have been suggested as a potential marker for mild cognitive impairment and Alzheimer’s disease, suggesting a role of LCN2-mediated iron homeostasis in the brain [21,22]. The gene discussed is LCN2; the disease is early-onset autosomal dominant Alzheimer disease.